title: Molecular mechanisms of endocrine and metabolic disruption: An in silico study on antitrypanosomal natural products and some derivatives.
abstract: The VirtualToxLab is an in silico technology for estimating the toxic potential - endocrine and metabolic disruption, as well as aspects of carcinogenicity and cardiotoxicity - of drugs, chemicals and natural products. The technology is based on an automated protocol that simulates and quantifies the binding of small molecules towards a series of currently 16 proteins, known or suspected to trigger adverse effects. The simulations are conducted at the atomic level and explicitly allow for a mechanistic interpretation of the results (in real-time 3D/4D), thereby complying with the Setubal principles put forward in 2002 for computational approaches to toxicology. Moreover, the underlying "ab-initio" protocol is independent from any training data and makes the approach universal with respect to the applicability domain. The VirtualToxLab runs in client-server mode and is freely available to academic and non-profit organizations. As the underlying technology yields a thermodynamic estimate of the binding affinity, the associated ligand-protein complexes have been challenged by molecular-dynamics simulations to probe their kinetic stability. Human African trypanosomiasis is a neglected tropical disease caused by two subspecies of Trypanosoma brucei. The control of this parasitic infection relies on a few chemotherapeutic agents, most of which were discovered decades ago and pose many challenges including adverse side effects, poor efficacy, and the occurrence of drug resistances. Natural products, on the other hand, offer a high potential for the discovery of new drug leads due to their chemical diversity. In this in silico study, we analyze a series of 89 natural products and derivatives displaying anti-trypanosomal activity for their potential to trigger adverse effects. Our results indicate a moderate potential for a number of those compounds to bind to nuclear receptors and thereby ease the development of endocrine disregulation. A few others would seem to inhibit enzymes of the cytochrome P450 family and, hence, sustain drug-drug interactions.
authors.affiliation: Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
authors.forename: Zhenquan
authors.initials: Z
authors.lastname: Hu
authors.affiliation: Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
authors.forename: Joël
authors.initials: J
authors.lastname: Wahl
authors.affiliation: Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
authors.forename: Matthias
authors.initials: M
authors.lastname: Hamburger
authors.affiliation: Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. Electronic address: angelo.vedani@unibas.ch.
authors.forename: Angelo
authors.initials: A
authors.lastname: Vedani
mesh_terms: D065607:Cytochrome P-450 Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity*; D004347:Drug Interactions; D052244:Endocrine Disruptors / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity*; D004734:Energy Metabolism / Q000187:drug effects*; D006801:Humans; D056004:Molecular Dynamics Simulation; D015394:Molecular Structure; D011485:Protein Binding; D011487:Protein Conformation; D015800:Protozoan Proteins / Q000378:metabolism; D018570:Risk Assessment; D013329:Structure-Activity Relationship; D014344:Trypanocidal Agents / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity*; D014346:Trypanosoma brucei brucei / Q000187:drug effects* / Q000378:metabolism
chemical_list: D065607:Cytochrome P-450 Enzyme Inhibitors; D052244:Endocrine Disruptors; D015800:Protozoan Proteins; D014344:Trypanocidal Agents
keywords: Adverse effects; Antitrypanosomal natural products; In silico profiling; Molecular-dynamics simulations; VirtualToxLab